# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Lake Street analyst Brooks O'Neil initiates coverage on MiMedx Group (NASDAQ:MDXG) with a Buy rating and announces Price...
Mizuho analyst Anthony Petrone maintains MiMedx Group (NASDAQ:MDXG) with a Buy and raises the price target from $13 to $14.
MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.07 ...